Merck (MRK) EVP exercises RSUs, holds over 185K shares via trusts
Rhea-AI Filing Summary
Merck & Co., Inc. executive vice president and president of MMD Sanat Chattopadhyay reported routine equity compensation activity. On April 29, 2026, he exercised 2,597 restricted stock units, converting them into the same number of Merck common shares. Of these, 1,130 shares were withheld to cover tax obligations, leaving a net increase in his directly held common stock. After these transactions, he directly owned 16,477 common shares and held additional indirect positions through three Grantor Retained Annuity Trusts, with 53,417, 57,622 and 74,289 common shares, respectively, over which he serves as sole trustee with complete investment control. He also continued to hold 5,194 restricted stock units that vest in three equal installments in 2026, 2027 and 2028.
Positive
- None.
Negative
- None.
Insights
Routine RSU vesting with tax withholding; minimal signal on Merck’s outlook.
Sanat Chattopadhyay exercised 2,597 restricted stock units into Merck common stock, a standard step when RSUs vest. The company withheld 1,130 shares, valued at about $110.03 each, to satisfy tax obligations, which is not an open‑market sale.
Following the transactions, he directly held 16,477 shares and maintained sizable indirect holdings via three Grantor Retained Annuity Trusts, totaling over 185,000 shares. He also retained 5,194 RSUs scheduled to vest on 4/29/2026, 4/29/2027, and 4/29/2028. These patterns indicate routine compensation management rather than a directional view on MRK.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 2,597 | $0.00 | -- |
| Exercise | Common Stock | 2,597 | $110.03 | $286K |
| Tax Withholding | Common Stock | 1,130 | $110.03 | $124K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The reporting person serves as the sole trustee of, and maintains complete investment control over, the Sanat Chattopadhyay April 2025 Grantor Retained Annuity Trust. The reporting person serves as the sole trustee of, and maintains complete investment control over, the Sanat Chattopadhyay August 2025 Grantor Retained Annuity Trust. The reporting person serves as the sole trustee of, and maintains complete investment control over, the Sanat Chattopadhyay February 2025 Grantor Retained Annuity Trust. Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.